# Effectiveness of Yunnan Baiyao in Improving Fracture Pain

> **NCT05765747** · NA · UNKNOWN · sponsor: **Peking University Third Hospital** · enrollment: 58 (estimated)

## Conditions studied

- Distal Radius Fracture

## Interventions

- **DRUG:** Yunnan Baiyao
- **DRUG:** Celecoxib 200mg

## Key facts

- **NCT ID:** NCT05765747
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-06-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05765747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05765747, "Effectiveness of Yunnan Baiyao in Improving Fracture Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05765747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*